/KASE, June 24, 2025/ – The financial statements of Black Biotechnology LLP (KASE ticker - BKBT) for 2024 and the auditor's report have been published.

According to the report of SFAI Kazakhstan LLP, the financial statements fairly reflect in all material aspects the financial position of Black Biotechnology LLP as of December 31, 2024, as well as its financial results and cash flows for the year ended on that date, in accordance with International Financial Reporting Standards (IFRS).

According to audited data as of December 31, 2024 (in thou. tenge, unless stated otherwise):

---------------------------------------------
                              as of     as of
Indicator                  12.31.24  12.31.23
------------------------- --------- ---------
Authorized capital           60,100    60,100
Equity (capital deficit)   -117,386     7,583
Total assets              2,359,270 1,965,079
Total liabilities         2,476,656 1,957,496
Revenue                     206,795   154,872
Gross profit (gross loss)   116,096   102,674
Net profit (net loss)      -124,969   -13,668
ROA, %                        -5.30     -0.70
ROE, %                       106.46   -180.25
ROS, %                       -60.43     -8.83
---------------------------------------------

Financial statements and report are published at see more

[2025-06-24]